HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 80 filers reported holding HARVARD BIOSCIENCE INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $478,000 | -64.2% | 77,034 | -59.4% | 0.00% | -50.0% |
Q4 2021 | $1,336,000 | -12.0% | 189,547 | -12.9% | 0.00% | 0.0% |
Q3 2021 | $1,519,000 | -45.5% | 217,619 | -34.9% | 0.00% | -33.3% |
Q2 2021 | $2,786,000 | +161.6% | 334,439 | +71.5% | 0.00% | +200.0% |
Q1 2021 | $1,065,000 | +24.6% | 194,970 | -2.2% | 0.00% | 0.0% |
Q4 2020 | $855,000 | +42.5% | 199,370 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $600,000 | +209.3% | 199,370 | +218.9% | 0.00% | – |
Q2 2020 | $194,000 | +312.8% | 62,514 | +193.5% | 0.00% | – |
Q1 2020 | $47,000 | -27.7% | 21,300 | 0.0% | 0.00% | – |
Q4 2019 | $65,000 | 0.0% | 21,300 | 0.0% | 0.00% | – |
Q3 2019 | $65,000 | -52.2% | 21,300 | -32.4% | 0.00% | – |
Q1 2019 | $136,000 | +7.9% | 31,492 | -20.3% | 0.00% | – |
Q4 2018 | $126,000 | -39.1% | 39,503 | 0.0% | 0.00% | – |
Q3 2018 | $207,000 | +53.3% | 39,503 | +56.7% | 0.00% | – |
Q2 2018 | $135,000 | +7.1% | 25,203 | 0.0% | 0.00% | – |
Q1 2018 | $126,000 | – | 25,203 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |